Terms: = Lung cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Staging
5 results:
1. Relationship of Oct-4 to malignant stage: a meta-analysis based on 502 positive/high Oct-4 cases and 522 negative/low case-free controls.
Zhong B; Lin Y; Lai Y; Zheng F; Zheng X; Huang R; Yang W; Chen Z
Oncotarget; 2016 Jan; 7(2):2143-52. PubMed ID: 26575328
[TBL] [Abstract] [Full Text] [Related]
2. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
[TBL] [Abstract] [Full Text] [Related]
3. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis.
Senthi S; Lagerwaard FJ; Haasbeek CJ; Slotman BJ; Senan S
Lancet Oncol; 2012 Aug; 13(8):802-9. PubMed ID: 22727222
[TBL] [Abstract] [Full Text] [Related]
4. Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients.
Szavcsur P; Godény M; Bajzik G; Lengyel E; Repa I; Trón L; Boér A; Vincze B; Póti Z; Szabolcs I; Esik O
Eur J Surg Oncol; 2005 Mar; 31(2):183-90. PubMed ID: 15698736
[TBL] [Abstract] [Full Text] [Related]
5. Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC).
Elias AD; Skarin AT; Leong T; Mentzer S; Strauss G; Lynch T; Shulman L; Jacobs C; Abner A; Baldini EH; Frei E; Sugarbaker DJ
Lung Cancer; 1997 May; 17(1):147-61. PubMed ID: 9194034
[TBL] [Abstract] [Full Text] [Related]